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Background: Epidermolysis bullosa (EB) comprises a group of hereditary disorders characterized by mechani-
cal fragility of the skin and mucous membranes, with the development of blisters and vesicles in response to 
minimum tissue friction. Recessive dystrophic epidermolysis bullosa (RDEB) with generalized involvement is the 
most common subtype in the oral cavity. The present study was carried out to investigate dental implant survival, 
peri-implant tissue condition, patient satisfaction, and the impact of treatment upon the quality of life of patients 
with RDEB rehabilitated with implants and full-arch implant-supported prostheses.
Material and Methods: Thirteen patients with RDEB underwent dental implant treatment between September 
2005 and December 2016. A retrospective study was made to analyze implant survival, peri-implant tissue health 
and patient satisfaction.
Results: A total of 80 implants were placed (42 in the maxilla and 38 in the mandible) in 13 patients between 20-52 
years of age and diagnosed with RDEB. All the implants were rehabilitated on a deferred basis with 20 full-arch 
prostheses. Fifteen fixed prostheses and 5 implant-supported overdentures were placed. The implant survival rate 
was 97.5% after a mean follow-up of 7.5 years after prosthetic loading. Fifty percent of the implants showed muco-
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Introduction
Epidermolysis bullosa (EB) comprises a group of in-
herited disorders characterized by mechanical fragil-
ity of the skin and mucous membranes, with the recur-
rent development of blisters and vesicles in response to 
the slightest friction (1).
The latest congress on the diagnosis and classification 
of the disease (Vienna 2007) classified EB into four 
groups and 32 subtypes. Among these groups, reces-
sive dystrophic epidermolysis bullosa (RDEB) with 
systemic involvement is the subtype most commonly 
found in the oral cavity. Recessive dystrophic epider-
molysis bullosa manifests as blisters all over the body, 
especially in areas of friction such as the hands, feet, 
elbows and knees (1,2). Such blisters usually lead to 
very painful ulcers that heal producing scars which 
in turn cause soft tissue contraction. Patients usually 
present syndactyly due to the continuous friction suf-
fered by the hands in daily life, and also esophageal 
stenosis, which causes obstruction of the digestive 
tract and secondary dysphagia (1-3).
Regarding the oral manifestations of RDEB, the numer-
ous blisters and ulcers result in scars that greatly alter 
the oral architecture, creating severe microstomia (lim-
ited mouth opening), ankyloglossia (adherence of the 
tongue to the floor of the mouth) and disappearance of 
the vestibule (2-4). Routine dental care proves very dif-
ficult in these patients, since any conventional brushing 
technique involves friction of the oral mucosa and thus 
causes the appearance of blisters and ulcers (Fig. 1).
For this reason, the presence of numerous and extensive 
caries and severe periodontal disease are very frequent 
in such patients, resulting in a loss of teeth at an early 
age (2).
The oral rehabilitation of these patients with dental im-
plants has been shown to offer high success rates over 
the short term, with significant improvement in qual-
ity of life (5-19). A functional dentition allows patients 
to improve their nutritional status (11) and reduces the 
potential for oral and esophageal soft tissue damage 
thanks to more efficient mastication (12,13). Moreover, 
dental implants can restore esthetics and self-esteem to 
these generally young patients. However, there are no 
data in the literature on the long-term success of dental 
implants or on the maintenance of peri-implant tissue 
health over time in patients with RDEB.
The aim of the present study was to evaluate implant 
and prosthetic treatment outcomes, peri-implant tissue 
health status and the satisfaction and quality of life of 
patients with RDEB rehabilitated using dental implants 
after a minimum follow-up of two years.
Material and Methods
A retrospective single cohort study was carried out in 
patients with RDEB treated with dental implants at the 
Oral Surgery and Implantology Clinic of the University 
of Valencia (Valencia, Spain) up until June 2018. Part 
of the patient sample included in the present study has 
been reported after shorter follow-up periods in several 
previous publications (7,9,10,14-16).
The selection criteria were: 1) patients diagnosed with 
RDEB; 2) edentulous or partially edentulous individu-
als (with teeth requiring extraction due to severe car-
ies or periodontal disease); 3) treatment with dental 
implants and full-arch fixed prosthesis or overdentures; 
and 4) a minimum follow-up period of two years after 
prosthetic loading.
The study was approved by the Ethics Committee of 
the University of Valencia with a procedure number 
H1404212828195. All the patients gave written in-
formed consent before the treatment, with specification 
that their data could be used for research purposes.
Before surgery, radiographic preoperative evaluation 
had been performed using panoramic radiographs and 
cone beam computed tomography (CBCT) scans. Prior 
to surgery, the lips of the patient were lubricated with 
vaseline, in the same way as the surgical instruments, 
sitis at the time of evaluation. Probing depth was maintained at 1-3 mm in 96.2% of the implants, and bleeding upon 
probing was observed in 67.5% of the implants. There was a high prevalence of bacterial plaque (85%).
Conclusions: The treatment of edentulous patients with RDEB by means of implants and implant-supported prosthe-
ses is predictable as evidenced by the high success rate, and improves patient self-esteem and quality of life.
 Key words: Epidermolysis bullosa, dental implants, implant-supported prostheses.
Fig. 1: Pre-treatment intraoral view showing the presence of teeth 
destroyed by rampant caries. Lesions are seen at the corners of the 
mouth and on the buccal and lingual mucosa.
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to avoid damaging the mucosa.
All surgeries had been carried out under conscious 
intravenous sedation using 1% propofol (Diprivan, 
Astra-Zeneca Pharma, Madrid, Spain) administered 
by an anesthetist. Local anesthesia was performed us-
ing 4% articaine and adrenaline 1:100,000 (Ultracain®, 
Aventis Pharma, Bad Soden, Germany), infiltrating 
the anesthetic solution deep into the tissues. Maxillary 
implants were placed combining drills and osteotomes 
to preserve the remaining bone and facilitate primary 
stability. In the mandible, conventional drilling was 
performed using the minimum necessary irrigation to 
reduce the use of aspiration. Three different implants 
were used: Phibo TSA® (Phibo Dental Solutions, Sent-
menat, Barcelona, Spain), Straumann Tissue Level® 
with SLA Surface (Straumann Institute, Waldenburg, 
Switzerland) and Ticare Inhex® implants (Mozo Grau, 
Valladolid, Spain).
Peri-implant defects were regenerated with particulate 
autologous bone collected during drilling, combined 
with tricalcium beta-phosphate (Kera-Os®, Keramat, 
Coruña, Spain), when the quantity of autologous bone 
proved insufficient. Resorbable collagen (Lyostypt®, 
B. Braun, Aesculap, Tuttlingen, Germany) was used to 
protect the particulate bone grafts.
Panoramic radiographs were taken immediately after 
surgery, and oral antibiotics (Clamoxyl®, Glaxo-Smith-
Kline; 500 mg every 8 hours for 7 days) and nonste-
roidal antiinflammatory drugs (Ibuprofen, Bexistar, 
Bacino Laboratory; 600 mg every 8 hours for 3 days) 
were prescribed. 
The implants remained until three months after 
placement in the mandible and 6 months in the max-
illa (Fig. 2).
When possible, clinical monitoring was carried out one 
and three months after surgery, and every 6 months af-
ter prosthetic loading. Panoramic radiographs were ob-
tained every 12 months to assess peri-implant marginal 
bone loss. Intraoral periapical radiographs could not be 
performed, as they would damage the soft tissues. Bone 
loss was controlled with the Rhinoceros® software 
(Robert McNeel & Associates. Seattle, USA); compar-
ing the initial radiography (radiography of the day of 
implant placement) with revision radiography. Follow-
ing the ideal monitoring and maintenance program was 
not possible in all cases, since many of the patients had 
important physical limitations or lived in other cities or 
countries.
During the last control visit, a predefined protocol was 
used to register implant and prosthetic treatment fail-
ure, peri-implant tissue health status and patient satis-
faction. Implants with mobility were removed due to 
progressive marginal bone loss or infection, and non-
usable implants due to mechanical complications were 
considered implant failures. Prosthetic treatment was 
considered a failure if it caused pain or discomfort or 
was not useful for restoring patient oral function (mas-
tication, phonation, esthetics).
Peri-implant tissue health status was assessed based on 
the following variables: 1) inflammation (redness and 
swelling); 2) the presence of suppuration; 3) the pres-
ence of plaque; 4) maximum probing pocket depth 
(PPD) measured with a millimetered periodontal probe 
(PCPUNC156, Hu-Friedy, Des Plaines, IL, USA) and 
classified into > or ≤ 3 mm; 5) bleeding on probing 
(BoP); 6) gingival recession, measured with a milli-
metered periodontal probe (PCPUNC156); and 7) the 
presence of keratinized mucosa (KM). Peri-implant 
marginal bone loss (< 2 mm or ≥ 2 mm) was assessed 
from panoramic radiographs, as intraoral radiographs 
were not available. With this information, the peri-im-
plant tissue health status of each implant was classified 
as healthy, mucositis or peri-implantitis.
Fig. 2: Keratinized periimplant mucosa after osseointegration of im-
plants placed in the premaxillary zone.
Prosthetic rehabilitation was performed using screw-re-
tained or cemented implant-supported fixed prostheses 
or overdentures (Fig. 3).
Fig. 3: Post-treatment intraoral view of the fixed upper full-arch 
prosthesis; designed with dynamic abutments and fixation screws 
that can be tightened from the buccal side at an angle of 25-30º.
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Patient satisfaction was evaluated using visual analog 
scales (VAS) from 0-10 with respect to the following 
aspects: general satisfaction, eating, speaking, esthet-
ics, cleansibility, hygiene, comfort and self-esteem. The 
quality of life was assessed with a questionnaire that 
we made exclusively for this type of patients; using the 
OHIP questionnaire on quality of life as a reference. We 
thought that a special questionnaire was necessary due 
to the characteristics of EB patients; asking questions 
which the patient will compare his current situation (af-
ter treatment) with the initial one. Each question was 
answered with the following options: never, rarely, oc-
casionally, very frequently.
Results
Thirteen patients (9 women and 4 men) that had received 
80 implants (42 in the maxilla and 38 in the mandible) 
were included in the study. The age of the patients at last 
follow-up ranged between 20-52 years (mean 33). Seven 
patients were treated of both arches. Fifteen implant-
supported fixed prostheses, of which 5 were screwed 
and 10 cemented, and 5 overdentures were used. The 
mean follow-up period was 7.7 years (range 2-15 years) 
after prosthetic loading.
Two implants failed (2.5%) - both located in the man-
dible. One failed during the osseointegration period 
and the other was removed due to mobility detected 12 
months after prosthetic loading. The clinical survival 
rate of the implants was 97.5%. With regard to the peri-
implant tissues, signs of inflammation were observed 
in 50% of the implants at the time of the clinical evalu-
ation. In 85% of the cases bacterial plaque was identi-
fied on the prosthesis and the implant prosthetic plat-
form. Bleeding upon probing was noted in 67.5% of 
the implants. In turn, peri-implant probing depth was 
maintained at 1-3 mm in 96.2% of the implants, though 
52.5% of the implants showed 0 mm retraction of the 
peri-implant mucosa. The presence of keratinized mu-
cosa in the buccal zone of the osseointegrated implants 
was noted in 62% of the cases; 40% with a width of the 
keratinized mucosa of 2-3 mm; and a 22% with a width 
of was 1 mm. The remaining 38% showed no keratin-
ized mucosa (mobile peri-implant soft tissue) (Table 1, 
Table 2).
Peri-implant bone loss after 7.7 years of follow-up 
was 1.65 ± 0.54 mm as determined from the pan-
oramic radiographs.
With regard to patient satisfaction after treatment, the 
mean score was over 9 for all the parameters evaluated 
(mastication, phonation, esthetics, comfort and self-es-
teem) except hygiene, which yielded a score of 6-8. The 
quality of life questionnaire after fitting of the prosthe-
sis also yielded positive results. Specifically, none of the 
patients claimed to feel ashamed of their mouth after 
treatment, and 76.9% rarely or never felt unable to go 
about their daily life routines normally (Table 3).
Location
Nº Retraction % Keratinized mucosa %
0mm 1-3mm +3mm NO YES
MAXILA 42 25 23.8 3.8 15 28
MANDIBLE 38 27.5 13.7 6.2 23 34
TOTAL 80 52.5 37.5 10 38 62
Table 1: Peri-implant soft tissue health: Quantity of retraction and keratinized mucosa.
Location Nº Presence of plaque % Presence of bleeding % Probing depth %Absence Presence Absence Presence 1-3 mm +3 mm
MAXILA 38 5 47.5 15 37.5 51.2 1.3
MANDIBLE 30 10 37.5 17.5 30 45 2.5
TOTAL 68 15 85 32.5 67.5 96.2 3.8
Table 2: Peri-implant tissue health: Presence of plaque, presence of bleeding and probing depth.
Never % Rarely % Occasionally % Frequently % Very Frequently %
Pronunciation problems 23.1 69.2 7.7 - -
Presence halitosis 69.2 23.1 7.7 - -
Presence pain 53.8 15.4 30.8 - -
Eating discomfort 76.9 15.4 7.7 - -
Feeling worried about the mouth 23.1 30.8 15.4 23.1 7.7
Ashamed because of the mouth 100 - - - -
Irritable due to the mouth 30.8 53.8 7.7 - 7.7
Feel difficulty at work 46.1 30.8 15.4 - 7.7
Feeling unable to do daily riutine 61.5 15.4 15.4 7.7 -
Table 3: Quality of life.
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Discussion
Implant-supported prosthetic rehabilitation of edentu-
lous patients with recessive dystrophic epidermolysis 
bullosa (RDEB) has been shown to afford high success 
rates (2,3,5) and is well tolerated by the patients. How-
ever, few data are available on the evolution of the peri-
implant tissues over time.
According to the literature, the success rate of dental 
implants placed in patients with RDEB ranges from 97-
100% (3,4,7). In our series we decided to assess implant 
survival in the mouth (97.5%) instead of the success 
rate, since the purpose of placing implants in patients 
of this kind is to afford function capable of ensuring 
improved nutrition. The literature makes no mention 
of the peri-implant tissues in patients with RDEB. In 
our study we assessed the peri-implant tissues based on 
measurements of gingival retraction, the presence or 
absence of keratinized mucosa and of bacterial plaque, 
and bleeding on probing and probing pocket depth. 
The results proved positive considering the skin and 
mucosal membranes of these patients, characterized 
by blisters that evolve towards ulcerations and retrac-
tile scars with substance loss. It is therefore clear that 
the peri-implant tissues suffer retraction associated to 
the prosthesis-implant gap, due to the ease with which 
bacteria accumulate at this interface. Mention also must 
be made of the problems these patients have for main-
taining adequate oral hygiene. Many of them have no 
hands or fingers, and others suffer digital atrophy with 
syndactyly. Microstomia and ankyloglossia are more-
over also observed. All this complicates the mechanical 
removal of bacterial plaque and explains the high preva-
lence of plaque end bleeding observed (85% and 67.5%, 
respectively) (2,3,4). Literature recommends the use of 
small and soft brushes, together with arms adapted for 
patients with physical limitations, or the prescription of 
chlorhexidine rinses as coadjuvant treatment (4).
The peri-implant bone loss observed (1.65 ± 0.54 mm) 
was greater than the values considered normal in pa-
tients without systemic disorders (0.06 ± 1.11 mm) (18). 
Nevertheless, the use of implants was justified, since 
their clinical survival rate was 97.5%. Oral rehabilita-
tion with implants in these patients results in improved 
mastication and swallowing, thereby stimulating the 
function of the stomatognathic system and optimizing 
food digestion. This in turn contributes to avoid esoph-
ageal stenosis secondary to the non-ingestion of solid 
foods. Furthermore, general patient health is improved, 
since being able to chew and swallow varied types of 
foods helps improve nutritional status (19).
With regard to patient satisfaction and quality of life, a 
study carried out by Peñarrocha-Oltra (7) on implant-
supported fixed prostheses in patients with RDEB 
recorded a mean score of 9 for all the variables eval-
uated (comfort, function, esthetics, phonation and self-
esteem). These results are consistent with those found 
in the literature (3,4). In our series we obtained a high 
score (9-10 points) for most parameters except oral hy-
giene, since the physical limitations inherent to RDEB, 
and the mucosal sequelae of brushing, greatly compli-
cate correct hygiene.
The prosthodontic management of these patients has 
experienced changes in recent years. Because of the 
microstomia characterizing RDEB and the very high 
risk of aspiration of prosthetic elements and drivers, 
the prosthesis used were cemented on premanufactured 
titanium abutments. The limited oral opening, added 
to the difficulty of obtaining a good impression, made 
it necessary to prepare a prosthesis with a more per-
missive fit for passive adjustment of the structure, and 
which did not pose oral opening problems when manip-
ulated in the mouth. Cemented prostheses require less 
oral opening for manipulation, since we do not need to 
insert the driver upon fitting the prosthetic structure.
The prosthesis can be fitted in sequence (first screw-
ing the abutments and then cementing the superstruc-
ture - the driver only being needed when placing the 
abutments). The main problem with prostheses of this 
kind is the difficulty of removing them. These patients 
are unable to observe correct oral hygiene, and the 
cemented prosthesis does not facilitate periodontal 
maintenance.
Agustín-Panadero (19) have described a new prosthetic 
alternative for these patients in the form of prostheses 
directly screwed to the implant platform produced by 
CAD/CAM processing with dynamic abutments al-
lowing the use of prosthetic fixation screws that can be 
tightened at an angle of 25-30 degrees. This means that 
the prosthetic structure can be screwed from outside 
the mouth, with no aspiration risk and no need to force 
oral opening. The screwed prosthesis is less voluminous 
than a cemented prosthesis and can be manipulated 
from outside the mouth. Furthermore, it can be removed 
each time the patient visits for periodontal maintenance, 
thereby improving the health of the peri-implant tissues. 
Since this design is very recent, only two patients in our 
study received this particular treatment.
The limitations of our study are the small sample size 
(13 patients) and the lack of uniform compliance with 
the patient follow-up visits and maintenance proce-
dures. This is explained by the fact that many of the 
patients lived in other cities or countries, and the physi-
cal limitations (wheelchair or treatments in the form of 
dialysis) prevented many of them from reporting to all 
the scheduled visits.
Conclusions
The results obtained in this study suggest that the treat-
ment of edentulous patients with RDEB by means of 
implants and implant-supported prostheses is predict-
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able as evidenced by the high success rate, and im-
proves patient stomatognathic function, self-esteem and 
quality of life.
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